Shao Di Pa Ning Decoction Attenuates Neuroinflammation in Parkinson’s Disease via PI3K/AKT Signaling Pathway
Mediators of Inflammation · 2026
DOI: 10.1155/mi/6450498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2026. Verfasst von Peng Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, Anhui, China, ahtcm.edu.cn. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Parkinson Disease. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research Project of Traditional Chinese Medicine Inheritance and Innovation of Anhui Province, Natural Science Research Key Project of Anhui Provincial Department of Education.
Abstract (Originalsprache)
Background
Parkinson’s disease (PD) is a neurodegenerative disorder with limited therapeutic options. Shao Di Pa Ning Decoction (SDPND), a traditional Chinese medicine (TCM) compound formula for PD, has demonstrated therapeutic efficacy, but its underlying mechanisms remain unclear.
Purpose
This research aims to systematically investigate the mechanisms of SDPND, focusing on its anti‐inflammatory effects and related pathways in PD.
Methods
The bioactive components of SDPND were first characterized to establish its material basis. Subsequently, A53T mice were administered SDPND to evaluate therapeutic improvements in motor dysfunction and neuroinflammatory responses, followed by transcriptomic profiling to identify potential pathways. Network pharmacology analysis was employed to validate biological pathways associated with these therapeutic effects. Molecular docking was used to study binding interactions between components and inflammatory, thereby offering mechanistic insights, with western blotting ultimately confirming the modulation of PI3K/AKT pathway activity.
Results
Chemical composition analysis revealed 91 compounds. SDPND alleviated motor deficits and mitigated neuroinflammatory responses in A53T mice. Transcriptomic profiling revealed significant downregulation of the PI3K/AKT pathway. Network pharmacology analyses independently reaffirmed the enrichment of PI3K/AKT signaling as a pivotal hub. Molecular docking demonstrated robust binding affinities between bioactive components and core targets within the PI3K/AKT pathway, while western blotting analysis confirmed SDPND mediated suppression of PI3K/AKT phosphorylation, further validating pathway inhibition as a key mechanistic driver.
Conclusion
Our findings first revealed a novel anti‐neuroinflammatory mechanism of SDPND via PI3K/AKT pathway suppression, which underlies its efficacy in mitigating PD symptoms. This discovery provides a robust theoretical foundation and pinpoints a strategic target for refining clinical PD therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, Anhui, China, ahtcm.edu.cn.
- Department of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China, ahtcm.edu.cn.
- Institute of Pharmaceutics, Anhui Academy of Chinese Medicine, Hefei 230012, Anhui, China, ahtcm.edu.cn.
- Key Laboratory of Xin'an Medicine, Ministry of Education, Hefei 230012, Anhui, China, moe.edu.cn.
- Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine, Institute of Health and Medicine Hefei Comprehensive National Science Center, Hefei 230012, Anhui, China.
ORCID-Profile: Jingjing Hu, Han Wang, Wenming Yang, Shuangying Gui, Yuzhe Huang
Förderung
- National Natural Science Foundation of China
- Research Project of Traditional Chinese Medicine Inheritance and Innovation of Anhui Province
- Natural Science Research Key Project of Anhui Provincial Department of Education
Zitieren
APA
Huang, P., Tao, Z., Hu, J., Dong, W., Wang, M., Wang, H., Dong, T., Zhang, Y., Liang, X., He, N., Yang, W., Gui, S., & Huang, Y. (2026). Shao Di Pa Ning Decoction Attenuates Neuroinflammation in Parkinson’s Disease via PI3K/AKT Signaling Pathway. Mediators of Inflammation. https://doi.org/10.1155/mi/6450498
Vancouver
Huang P, Tao Z, Hu J, Dong W, Wang M, Wang H, et al. Shao Di Pa Ning Decoction Attenuates Neuroinflammation in Parkinson’s Disease via PI3K/AKT Signaling Pathway. Mediators of Inflammation. 2026. doi:10.1155/mi/6450498
BibTeX
@article{Huang2026,
author = {Huang, Peng and Tao, Zhengqi and Hu, Jingjing and Dong, Wei and Wang, Meixia and Wang, Han and Dong, Ting and Zhang, Yun and Liang, Xiao and He, Ning and Yang, Wenming and Gui, Shuangying and Huang, Yuzhe},
title = {Shao Di Pa Ning Decoction Attenuates Neuroinflammation in Parkinson’s Disease via PI3K/AKT Signaling Pathway},
journal = {Mediators of Inflammation},
year = {2026},
doi = {10.1155/mi/6450498}
}
EUVIMED